Hemispherian
Oslo
About Hemispherian
Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $17.7M
- Funding stage: Early Stage Venture
- Last round: Grant (Dec 2023)
- Website: hemispherian.com
- Phone: +47 406 03 455
Industries & Categories
Biotechnology, Consulting, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/hemispherian-84897 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.